Interview with Yukichi Hatano | 2025 Viral Safety & Viral Clearance Summit

Описание: Yukichi Hatano, a representative from JCR Pharmaceutical in Japan, is scheduled to present on the topic of virus co-spiking in an actual virus clearance study during the second day of an upcoming summit. Although the co-spiking method has already been developed by Charles River, Hatano aims to share insights from applying this technique in their specific project. His presentation will focus on comparing single spiking and co-spiking runs using real experimental data. He acknowledges the challenges, particularly the slight differences observed between the two methods, and intends to explore these differences in greater detail. Hatano also plans to collect additional data to better understand the expanded application of co-spiking. A significant aspect of the summit for him is to gain perspectives from regulatory agencies such as the European Medicines Agency (EMEA) and the Paul-Ehrlich-Institut (PEI), highlighting the importance of regulatory feedback. Overall, Hatano sees the summit as an opportunity for learning and advancing knowledge in virus clearance methodologies.

https://bit.ly/4mDMOOS